The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1524-1528

  Kim, Jung Eun ^a   Jun, Soojin ^a   Song, Minji ^a   Kim, Joo Hwan ^a   Song, Yoon Jae ^a  

^a Gachon University   (South Korea)

Author keywords

Chrysanthemum indicum Linne; Epstein Barr virus; Latent membrane protein 1; NF B

Indexed keywords

ALCOHOL; CHRYSANTHEMUM INDICUM EXTRACT; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT INFECTION MEMBRANE PROTEIN 1; PLANT EXTRACT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CELL TRANSFORMATION; CELL VIABILITY; CHRYSANTHEMUM INDICUM; CONTROLLED STUDY; DRUG SCREENING; EPSTEIN BARR VIRUS; HELA CELL; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PREPUCE; PROTEIN PROTEIN INTERACTION; SKIN FIBROBLAST; TRANSCRIPTION INITIATION; VIRUS CELL INTERACTION;

CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CHRYSANTHEMUM; HUMANS; NF-KAPPA B; PLANT EXTRACTS; VIRAL MATRIX PROTEINS;

CHRYSANTHEMUM INDICUM; HUMAN HERPESVIRUS 4;

EID: 84859855891     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.02.034     Document Type: Article

References (40)

1. Atkinson P.G., Coope H.J., Rowe M., Ley S.C. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. Journal of Biological Chemistry 2003, 278:51134-51142.
2. Bari W., Song Y.J., Yoon S.S. Suppressed induction of proinflammatory cytokines by a unique metabolite produced by Vibrio cholerae O1 El Tor biotype in cultured host cells. Infection and Immunity 2011, 79:3149-3158.
3. Cahir-McFarland E.D., Carter K., Rosenwald A., Giltnane J.M., Henrickson S.E., Staudt L.M., Kieff E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. Journal of Virology 2004, 78:4108-4119.
4. Cahir-McFarland E.D., Davidson D.M., Schauer S.L., Duong J., Kieff E. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:6055-6060.
5. Cheng W., Li J., You T., Hu C. Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linne. Journal of Ethnopharmacology 2005, 101:334-337.
6. Cheon M.S., Yoon T., Lee do Y., Choi G., Moon B.C., Lee A.Y., Choo B.K., Kim H.K. Chrysanthemum indicum Linne extract inhibits the inflammatory response by suppressing NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophages. Journal of Ethnopharmacology 2009, 122:473-477.
7. Chun H.S., Kim J.M., Choi E.H., Chang N. Neuroprotective effects of several korean medicinal plants traditionally used for stroke remedy. Journal of Medicinal Food 2008, 11:246-251.
8. Devergne O., Cahir McFarland E.D., Mosialos G., Izumi K.M., Ware C.F., Kieff E. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. Journal of Virology 1998, 72:7900-7908.
9. Devergne O., Hatzivassiliou E., Izumi K.M., Kaye K.M., Kleijnen M.F., Kieff E., Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Molecular and Cellular Biology 1996, 16:7098-7108.
10. Gao M.H., Li H., Zhang L., Xiao S.X. Studies on chemical constituents from flowers of Chrysanthemum indicum. Zhong Yao Cai 2008, 31:682-684.
11. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-96.
12. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes & Development 2004, 18:2195-2224.
13. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65:1107-1115.
14. Huen D.S., Henderson S.A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995, 10:549-560.
15. Hurley E.A., Klaman L.D., Agger S., Lawrence J.B., Thorley-Lawson D.A. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. Journal of Virology 1991, 65:3958-3963.
16. Izumi K.M., Cahir McFarland E.D., Riley E.A., Rizzo D., Chen Y., Kieff E. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. Journal of Virology 1999, 73:9908-9916.
17. Kato T., Noguchi K., Miyamoto Y., Suekawa M., Aburada M., Hosoya E., Sakanashi M. Effects of Chrysanthemum indicum Linn. on coronary, vertebral, renal and aortic blood flows of the anesthetized dog. Archives internationales de pharmacodynamie et de thérapie 1987, 285:288-300.
18. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:11085-11090.
19. Kaye K.M., Izumi K.M., Mosialos G., Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. Journal of Virology 1995, 69:675-683.
20. Kieff, E.D., Rickinson, A.B., 2007. Epstein-Barr Virus and Its Replication, in: D.M. Knipe, P.M. Howley (Eds.), Fields Virology, 2007 ed. Lippincott, Williams, and Wilkins Philadelphia, pp. 2603-2655.
21. Kim I.S., Ko H.M., Koppula S., Kim B.W., Choi D.K. Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson's disease. Food and Chemical Toxicology 2011, 49:963-973.
22. Kulwichit W., Edwards R.H., Davenport E.M., Baskar J.F., Godfrey V., Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11963-11968.
23. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347.
24. Lee do Y., Choi G., Yoon T., Cheon M.S., Choo B.K., Kim H.K. Anti-inflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation. Journal of Ethnopharmacology 2009, 123:149-154.
25. Matsuda H., Morikawa T., Toguchida I., Harima S., Yoshikawa M. Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chemical and Pharmaceutical Bulletin (Tokyo) 2002, 50:972-975.
26. Mitchell T., Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. Journal of Virology 1995, 69:2968-2976.
27. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995, 80:389-399.
28. Pongjit K., Ninsontia C., Chaotham C., Chanvorachote P. Protective effect of glycine max and chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death. Human & Experimental Toxicology 2011, 278.
29. Rickinson, A.B., Kieff, E.D., 2007. Epstein-Barr Virus, in: D.M. Knipe, P.M. Howley (Eds.), Fields Virology, Fifth ed. Lippincott, Williams, and Wilkins, Philadelphia, Pa, pp. 2655-2700.
30. Saito N., Courtois G., Chiba A., Yamamoto N., Nitta T., Hironaka N., Rowe M., Yamamoto N., Yamaoka S. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines. Journal of Biological Chemistry 2003, 278:46565-46575.
31. Shunying Z., Yang Y., Huaidong Y., Yue Y., Guolin Z. Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. Journal of Ethnopharmacology 2005, 96:151-158.
32. Song Y.J., Izumi K.M., Shinners N.P., Gewurz B.E., Kieff E. IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18448-18453.
33. Song Y.J., Stinski M.F. Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. Journal of Virology 2005, 79:2597-2603.
34. Stinski M.F. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. Journal of Virology 1977, 23:751-767.
35. Su J.Y., Tan L.R., Lai P., Liang H.C., Qin Z., Ye M.R., Lai X.P., Su Z.R. Experimental study on anti-inflammatory activity of a TCM recipe consisting of the supercritical fluid CO(2) extract of Chrysanthemum indicum, Patchouli oil and Zedoary turmeric oil in vivo. Journal of Ethnopharmacology 2011.
36. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43:831-840.
37. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. Journal of Virology 1988, 62:4173-4184.
38. Wang Z.D., Huang C., Li Z.F., Yang J., Li B.H., Liang R.R., Dai Z.J., Liu Z.W. Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncology reports 2010, 23:413-421.
39. Yoshikawa M., Morikawa T., Murakami T., Toguchida I., Harima S., Matsuda H. Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L. Chemical and Pharmaceutical Bulletin (Tokyo) 1999, 47:340-345.
40. Yoshikawa M., Morikawa T., Toguchida I., Harima S., Matsuda H. Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chemical and Pharmaceutical Bulletin (Tokyo) 2000, 48:651-656.